In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial)
- 1 January 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 162, 24-30
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pathology of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft LesionsJACC: Cardiovascular Interventions, 2012
- Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) TrialJACC: Cardiovascular Interventions, 2011
- Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure After StentingJACC: Cardiovascular Interventions, 2009
- A Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft LesionsJACC, 2009
- Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein GraftsJACC, 2007
- Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein GraftsJACC, 2006
- Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre studyHeart, 2006
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent StudyCatheterization and Cardiovascular Interventions, 2003
- Stent Placement Compared with Balloon Angioplasty for Obstructed Coronary Bypass GraftsNew England Journal of Medicine, 1997